1 Bicycle Therapeutics Plc Receivables Turnover Ratio (BCYC), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bicycle Therapeutics Plc  (NASDAQ: BCYC)
 

Bicycle Therapeutics Plc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Bicycle Therapeutics Plc Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Bicycle Therapeutics Plc Balance Sheet

If we take a look into Healthcare sector 450 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2735, from overall ranking in the fourth quarter 2025 at 2848.

What is Receivable Turnover Ratio?
What is Bicycle Therapeutics Plc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BCYC Receivables Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change -91.11 % 1193.28 % 338.49 % -68.81 % -48.91 %
Receivable Turnover Ratio (TTM) - 2134.88 833.5 567.09 278.83
BCYC's Total Ranking # 2735 # 2848 # 16 # 10 # 3506
Accounts Receivable average collection period days - 0 0 1 1
Seq. Receivable Change - - - - -
Seq. Revenue Change -98.15 % 308.68 % 301.85 % -70.73 % 169.07 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 157
Healthcare Sector # 451
Overall Market # 2735

Receivable Turnover Ratio Statistics
High Average Low
0.09 0.05 0.02
(Dec 31 2025)   (Jun 30 2025)





BCYC Company Profile • Back to BCYC Efficiency Comparisons • Compare BCYC Receivables Turnover Ratio to its Competitors

Financial Statements
Bicycle Therapeutics Plc's Accounts Receivable $ 0 Millions Visit BCYC's Balance sheet
Bicycle Therapeutics Plc's Sales TTM $ 63 Millions Visit BCYC's Income Statement
Sources of BCYC's Revenues Visit BCYC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BCYC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BCYC's Growth Rates BCYC's Roa BCYC's Inventory Turnover Ratio BCYC's Dividend Comparisons
BCYC's Profitability Ratios BCYC's Roi BCYC's Asset Turnover Ratio BCYC's Dividend Growth
BCYC's Valuation Ratios BCYC's Roe BCYC's Financial Strength Ratios BCYC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-30T15:00:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.